DeSantis Robert - Mar 8, 2024 Form 4 Insider Report for INTUITIVE SURGICAL INC (ISRG)

Role
EVP & Chief Strategy & Corp Op
Signature
By: Donna Spinola For: DeSantis, Robert
Stock symbol
ISRG
Transactions as of
Mar 8, 2024
Transactions value $
-$3,657,479
Form type
4
Date filed
3/11/2024, 08:11 PM
Previous filing
Feb 29, 2024
Next filing
Apr 30, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISRG Common Stock Options Exercise $437K +1.5K +13.58% $290.33 12.6K Mar 8, 2024 Direct F1
transaction ISRG Common Stock Sale -$592K -1.5K -11.96% $393.81 11.1K Mar 8, 2024 Direct F1, F2
transaction ISRG Common Stock Options Exercise $2.48M +7.15K +64.55% $347.42 18.2K Mar 8, 2024 Direct F1
transaction ISRG Common Stock Sale -$2.82M -7.15K -39.23% $393.78 11.1K Mar 8, 2024 Direct F1, F3
transaction ISRG Common Stock Options Exercise $244K +993 +8.97% $245.60 12.1K Mar 8, 2024 Direct F1
transaction ISRG Common Stock Sale -$391K -993 -8.23% $393.80 11.1K Mar 8, 2024 Direct F1, F4
transaction ISRG Common Stock Options Exercise $110K +453 +4.09% $242.34 11.5K Mar 8, 2024 Direct F1
transaction ISRG Common Stock Sale -$178K -453 -3.93% $393.80 11.1K Mar 8, 2024 Direct F1, F4
transaction ISRG Common Stock Options Exercise $65.2K +363 +3.28% $179.70 11.4K Mar 8, 2024 Direct F1
transaction ISRG Common Stock Sale -$143K -363 -3.17% $393.80 11.1K Mar 8, 2024 Direct F1, F5
transaction ISRG Common Stock Options Exercise $80.6K +453 +4.09% $177.99 11.5K Mar 8, 2024 Direct F1
transaction ISRG Common Stock Sale -$178K -453 -3.93% $393.80 11.1K Mar 8, 2024 Direct F1, F5
transaction ISRG Common Stock Options Exercise $438K +1.44K +12.98% $304.67 12.5K Mar 8, 2024 Direct F1
transaction ISRG Common Stock Sale -$566K -1.44K -11.48% $393.80 11.1K Mar 8, 2024 Direct F1, F6
transaction ISRG Common Stock Options Exercise $329K +1.44K +12.97% $229.39 12.5K Mar 8, 2024 Direct F1
transaction ISRG Common Stock Sale -$566K -1.44K -11.48% $393.82 11.1K Mar 8, 2024 Direct F1, F7
transaction ISRG Common Stock Options Exercise $196K +940 +8.49% $208.90 12K Mar 8, 2024 Direct F1
transaction ISRG Common Stock Sale -$370K -940 -7.82% $393.82 11.1K Mar 8, 2024 Direct F1, F7
transaction ISRG Common Stock Sale -$1.11M -2.82K -25.45% $393.79 8.26K Mar 8, 2024 Direct F1, F8
transaction ISRG Common Stock Sale -$1.08M -2.75K -33.3% $393.83 5.51K Mar 8, 2024 Direct F1, F9
transaction ISRG Common Stock Options Exercise $16.2K +90 +1.63% $179.70 5.6K Mar 11, 2024 Direct F1
transaction ISRG Common Stock Sale -$35.1K -90 -1.61% $390.16 5.51K Mar 11, 2024 Direct F1
transaction ISRG Common Stock Options Exercise $36.3K +119 +2.16% $304.67 5.63K Mar 11, 2024 Direct F1
transaction ISRG Common Stock Sale -$46.4K -119 -2.12% $390.16 5.51K Mar 11, 2024 Direct F1
transaction ISRG Common Stock Options Exercise $27.5K +120 +2.18% $229.39 5.63K Mar 11, 2024 Direct F1
transaction ISRG Common Stock Sale -$46.8K -120 -2.13% $390.16 5.51K Mar 11, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -453 -100% $0.00* 0 Mar 8, 2024 Common Stock 453 $177.99 Direct F1, F10
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -363 -57.35% $0.00 270 Mar 8, 2024 Common Stock 363 $179.70 Direct F1, F11
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -90 -33.33% $0.00 180 Mar 11, 2024 Common Stock 90 $179.70 Direct F1, F11
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -940 -17.24% $0.00 4.51K Mar 8, 2024 Common Stock 940 $208.90 Direct F1, F12
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -1.44K -24.99% $0.00 4.31K Mar 8, 2024 Common Stock 1.44K $229.39 Direct F1, F13
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -120 -2.78% $0.00 4.19K Mar 11, 2024 Common Stock 120 $229.39 Direct F1, F13
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -453 -100% $0.00* 0 Mar 8, 2024 Common Stock 453 $242.34 Direct F1, F12
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -993 -29.42% $0.00 2.38K Mar 8, 2024 Common Stock 993 $245.60 Direct F1, F10
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -1.5K -25% $0.00 4.51K Mar 8, 2024 Common Stock 1.5K $290.33 Direct F1, F10
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -1.44K -25.01% $0.00 4.31K Mar 8, 2024 Common Stock 1.44K $304.67 Direct F1, F14
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -119 -2.76% $0.00 4.19K Mar 11, 2024 Common Stock 119 $304.67 Direct F1, F14
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -7.15K -75.01% $0.00 2.38K Mar 8, 2024 Common Stock 7.15K $347.42 Direct F1, F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024.
F2 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $391.89 to $394.82 as follows: 327 shares sold at $391.89 to $392.02; 1,077 shares sold at $393.73 to $394.61; and 100 shares sold at $394.82. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $391.89 to $395.05 as follows: 1,277 shares sold at $391.89 to $392.02; 157 shares sold at $392.50 to $392.52; 4,145 shares sold at $393.53 to $394.53; and 1,570 shares sold at $394.56 to $395.05. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F4 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $391.89 to $395.00 as follows: 318 shares sold at $391.89 to $392.02; 1,028 shares sold at $393.72 to $394.61; and 100 shares sold at $395.00. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F5 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $391.89 to $394.80 as follows: 223 shares sold at $391.89 to $392.02 and 593 shares sold at $394.00 to $394.80. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F6 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $391.89 to $395.00 as follows: 317 shares sold at $391.89 to $392.02; 1,020 shares sold at $393.72 to $394.61; and 100 shares sold at $395.00. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F7 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $391.89 to $395.32 as follows: 458 shares sold at $391.89 to $392.02; 780 shares sold at $393.22 to $394.14; 1,134 shares sold at $394.27 to $394.82; and 4 shares sold at $395.32. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F8 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $391.89 to $394.82 as follows: 525 shares sold at $391.89 to $392.02; 1,876 shares sold at $393.55 to $394.53; and 418 shares sold at $394.60 to $394.82. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F9 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $391.89 to $394.82 as follows: 515 shares sold at $391.89 to $392.02; 2,034 shares sold at $393.65 to $394.61; and 200 shares sold at $394.60 to $394.82. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F10 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.
F11 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The grant vests 25% on the first anniversary of the date of grant and monthly thereafter, over a four year period of time.
F12 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.
F13 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date.
F14 7/48th of the shares subject to the option vest on the one-month anniversary measured from August 10, 2023, and 1/48th of the total number of shares vest in forty-one (41) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date.